FAM
OLMA icon

Fred Alger Management’s Olema Pharmaceuticals OLMA Stock Holding History

Fred Alger Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-64,484
Closed -$1.61M – 496
2025
Q4 		$1.61M Buy
+64,484
New +$1.15M 0.01% 328
2024
Q1 		– Sell
-39,584
Closed -$555K – 482
2023
Q4 		$555K Buy
+39,584
New +$532K ﹤0.01% 387
2021
Q4 		– Sell
-92,785
Closed -$2.56M – 545
2021
Q3 		$2.56M Buy
+92,785
New +$2.5M 0.01% 336

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Fred Alger Management's OLMA Position: Q1 2026 in Review

Fred Alger Management sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 64,484 shares — an estimated $1.61M sold.

Fred Alger Management first reported a position in OLMA in Q3 2021 and held it in 3 quarters. The position peaked at $2.56M in Q3 2021. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Fred Alger Management reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Fred Alger Management sold 64,484 Olema Pharmaceuticals shares in Q1 2026, an estimated $1.61M.
  • Fred Alger Management first reported a position in Olema Pharmaceuticals in Q3 2021 and held it in 3 quarters.
  • Fred Alger Management's Olema Pharmaceuticals position peaked at $2.56M in Q3 2021.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.